This is the authors' abstract. We don't add key points for this paper.
SummaryTwenty patients with classical or definite rheumatoid arthritis (R.A.) were treated with D penicillamine, six were withdrawn from the study between the 4th and 18th weeks of treatment: 2 for lack of improvement, 2 for thrombocytopenia and 2 for proteinuria.Fourteen patients with a good response to a 31 week long treatement and without untoward effects on renal, liver and haematological functions were selected for this study. The serum hemolytic complement (CH50), the complement components C3, C4 and C5; the serum levels of immunoglobulins IgA, IgM and IgG, together with other biological and clinical parameters were measured during the course of treatment.The study of these patients revealed a significant decrease of IgA and IgG levels and an improvement of inflammatory parameters correlating with the clinical evolution. D-pcnicillamine had no effect on complement components C3, C4 and C5 while an increase of CH50 from the 7th week onwards, after an initial period of decrease was observed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mbuyi-Muamba et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: